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Ca2+-sensitive thin filaments from vascular smooth muscle were disassembled into their constituent proteins, 
actin, tropomyosin and caldesmon. Caldesmon bound to both actin and to actin-tropomyosin and inhibited 
actin-tropomyosin activation of skeletal muscle myosin MgATPase. It also promoted the aggregation of 
actin or actin-tropomyosin into parallel aligned bundles. Quantitative electron microscopy measurements 
showed that with 1.1 PM actin-tropomyosin, 1.6 &- 0.5% (n= 3) of the filaments were in bundles. At 0.073 
PM, caldesmon inhibited MgATPase activity by SO%, whereas bundling was 3.0 + 1.3% (n =4) .At 0.37 
PM caldesmon, MgATPase inhibition was 83% while 28.1 + 6.9% (n=4) of filaments were in bundles. 
Experiments at 4.4 PM in which MgATPase and bundling were measured in the same samples gave similar 
results. Small bundles of 2-3 filaments showed the most frequent occurrence at 1.1 PM actin. At 4.4 PM 
actin the most common bundle size was 35 filaments, with the occasional occurrence of large bundles con- 
sisting of up to 120 filaments. The incidence of bundling was the same in the presence and absence of tropo- 
myosin. Thus caldesmon can induce the formation of actin bundles but this property bears no relationship 
to its inhibition of MgATPase activity. 
Smooth muscle Caldesmon Actin 
1. INTRODUCTION F-actin at a molar ratio of 1: 25-30 [4]. 
Ca’+-sensitive regulation of vascular smooth 
muscle (vsm) thin filaments has recently been 
demonstrated using native thin filaments [l], and 
with a reconstituted system consisting of F-actin, 
myosin, tropomyosin, calmodulin and a 120 kDa 
protein [2,4]. The 120 kDa thin filament associated 
inhibitory protein is now known to be identical 
with caldesmon [3]. Inhibition of actin-activated 
myosin Mg’+-ATPase activity by caldesmon is 
relieved when Ca2+ binds to calmodulin added to 
the system. 
Binding studies show that vsm caldesmon binds 
to both calmodulin and to actin (or actin-tropo- 
myosin), and that binding to calmodulin is calcium- 
sensitive [ 1,121. The stoichiometry of high affinity 
binding, inhibition of Mg2+-ATPase activity and 
the native occurrence of caldesmon in vsm thin 
filaments all suggest that caldesmon interacts with 
Tropomyosin Ca2+ regulation 
A number of proteins are known to cross-link or 
to bundle F-actin (e.g. fodrin [5], filamin [6], 
myosin subfragment-l [13], troponin-I and myelin 
basic protein [14]) and recent reports show that 
caldesmon shares this property [7-91 in addition to 
an ability to accelerate nucleation and to induce 
polymerization of G-actin [lo]. 
In this study we investigated whether bundling is 
the mechanic underlying vsm caldesmon inhibition 
of actomyosin MgATPase activity using electron 
microscopy to visualize the filaments and filament 
bundles. Bundle formation was related to simul- 
taneous measurements of vsm caldesmon binding 
to actin and to inhibition of actomyosin ATPase 
activity. 
2. MATERIALS AND METHODS 
Sheep aorta thin filaments, F-actin, tropomyosin, 
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caldesmon, and skeletal muscle myosin were 
freshly prepared and purified by the methods 
detailed by Marston and Smith [l] and Smith and 
Marston [4]. 
2.1. Electron microscope studies 
Preliminary experiments showed that electron 
micrographs of long, separate, randomly orien- 
tated filaments, spaced sufficiently for counting, 
were obtained using grids prepared from about 1 
PM F-actin solutions. 
F-Actin solutions (1.1 PM) were prepared in buf- 
fer A (0.1 mM dithiothreitol, 10 mM NaN3, 10 mM 
Tris-Mes, 60 mM KCl, 5 mM MgCL, 6 mM 
KH~POJKZHPO~ and 0.1 mM CaC12 at 4°C and 
pH 7), shaken for 10 s and left to disperse for a 
minimum of 30 min. All procedures took place at 
4”C, as this was found to preserve actin filaments 
in better structural detail than preparation at room 
temperature. Tropomyosin was added to some ac- 
tin solutions at a molar ratio f 1: 7 and caldesmon 
was added to give a range of molar ratios (1: 3- 
1 : 100). Solutions were allowed to stand for a 
period of 15 min before preparation of grids for 
electron microscopy. 
Carbon-strengthened celloidin-coated 300-mesh 
copper grids (Agar Aids) were used. The central 
area of these grids is characterized by the letter 
‘A’. One drop of protein solution was applied to 
the grid, followed by 3 drops of buffer and 3 drops 
of 1% uranyl acetate (aqueous). Grids were blotted 
and left to dry at room temperature. Three repli- 
cate grids were prepared from each protein solu- 
tion. Grids were examined using a Philips 301 elec- 
tron microscope at an accelerating voltage of 60 
kV. 
The central A portion of the grid was used to 
locate 7 separate pre-determined grid squares. 
Electron micrographs of the top left-hand corner 
of each square (image dimensions 27.4 x 35.7pm) 
were taken and printed to a final magnification of 
x 84000. The total number of F-actin filaments 
(mean f SE = 60 +- 2, for n = 4 protein prepara- 
tions) and the number of F-actin filaments in- 
volved in bundles were recorded for each micro- 
graph. Bundles were defined as the close parallel 
alignment of 2 or more actin filaments. Micro- 
graphs were counted ‘blind’ and grids were la- 
belled in a random order. Data from replicate grids 
were pooled and any F-actin interactions expressed 
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as a percentage of the total number of filaments. 
The experiment was repeated with 4 actin, 
tropomyosin and caldesmon preparations. 
2.2. Comparison of caldesmon inhibition of 
MgA TPase activity, actin binding and 
bundling 
4.4,uM actin saturated with tropomyosin was in- 
cubated with O-3.5 FM caldesmon covalently 
labelled with iodo[14C]acetamide (40 cpm/pmol) at 
4°C in buffer B (as buffer A, but without phos- 
phate). At each caldesmon concentration, samples 
were taken (in triplicate) and placed on electron 
microscope grids for quantitative examination of 
size and fequency of bundles. Further samples 
were: (i) mixed with 4.4,uM skeletal muscle myosin 
for the determination of MgATPase activity [4] at 
4°C. The reaction was initiated by the addition of 
MgATP to 1 mM, and terminated by the addition 
of trichloroacetic acid to 5% after 30 min incuba- 
tion. (ii) Used in the sedimentation assay [4] for the 
measurement of binding. In a total volume of 250 
~1, 80-~1 aliquots were taken before and after cen- 
trifugation for 2 h at 50 000 x g. Samples contain- 
ing no actin were also run, to account for [i4C]cal- 
desmon which sediments in the absence of actin. 
Samples were assayed by liquid scintillation 
counting. Caldesmon bound to actin was equated 
to the difference in supernatant cpm before and 
after sedimentation. 
3. RESULTS 
3.1. Caldesmon binding to actin-tropomyosin and 
inhibition of actin activation of myosin 
MgA TPase 
In this study all measurements were made at 
4”C, since this was optimal for the visualization of 
filaments using electron microscopy. Under these 
conditions, low concentrations of vsm caldesmon 
inhibited actin-tropomyosin activation of myosin 
MgATPase activity (figs 1 and 2) while less inhibi- 
tion of actin activation was seen. For example, 
with 2.5 PM actin, inhibition of actin-tropomyosin 
activation by 0.12 PM caldesmon (molar ratio of 
0.048 caldesmon/actin), was 50% while only 10% 
inhibition of actin activation was found. With 0.9 
PM caldesmon (0.36 caldesmon/actin) inhibition 
was 90% for actin-tropomyosin and 60% for 
actin. 
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Fig.1. (a) Scatchard plot of binding of vsm iodo[14C]- 
acetamide labelled caldesmon (O-3.5 PM) to 4.4 PM vsm 
F-actin (A) or to actin-tropomyosin (0) at 4°C. Binding 
was determined by the sedimentation assay. The data 
was analysed on the basis of 2 classes of independent 
binding sites. An initial fit was obtained by a visual 
iterative procedure [ 11,151; solid lines on graph. For 
actin-tropomyosin the weaker class of binding was 
estimated as Km = 6 pM, B, = 0.12 caldesmon/actin 
and the strong binding was estimated as K, = 25 nM, 
B, = 0.034 caldesmon/actin. The contribution of the 
weak binding was calculated and subtracted from the 
total binding and the residual (strong) binding was fur- 
ther ana.Iysed by fitting to the equation for a single class 
of binding sites [16] to yield K, = 24 f 4 nM, B, = 
0.035 * 0.001 (mean + SE, n = 15 observations). The 
curve fitted to the actin data has the parameters: strong, 
K, = 46 nM, B,,, = 0.032; weak, K,,, = 6.0pM, B, = 
0.12 caldesmon/actin. (b) Correlation of caldesmon 
binding with inhibition of actin activation of myosin 
MgATPase. Data from figs la,2. Actin (A), actin- 
tiopomyosin (0). The line drawn was calculated after 
least-squares linear regression analysis of data in the 
rageO-80% inhibition. Parameters for actin-tropomyosin 
are: correlation coefficient, 0.995; intercept 100% in- 
hibition, 0.041 caldesmon/actin; slope, 2111% per 
molar ratio caldesmon/actin; abscissa intercept, 2%. 
0’2 0’4 0’6 
Caldesmon added hl/mol actln) 
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Fig.2. Comparison of bundling and inhibition induced 
by vsm caldesmon using the same protein preparation. 
4.4pM vsm actin-tropomyosin was incubated with O-3.5 
pM caldesmon at 4°C in buffer B. Samples were taken 
for measurement of bundle size and frequency (0) and 
activation of skeletal myosin (4.4pM) MgATPase activi- 
ty (0). Results are plotted in terms of percentage inhibi- 
tion of the MgATPase activation found in the absence of 
caldesmon (30 nmol/min per mg myosin). Samples were 
also taken for measurement of actin-caldesmon binding 
- results shown in fig.1. 
Measurement of the binding of caldesmon (iodo- 
[‘4C]acetamide-labelled) to actin-tropomyosin 
showed that binding was not simple. It was ana- 
lysed in terms of 2 classes of binding site by the 
procedures which have proved successful with bind- 
ing measurements at 25°C [4,11,15] (fig. la). The 
stronger class of binding sites had an estimated 
binding constant of 4.1 x 10’ M-’ and a max: 
imum binding of 1 caldesmon per 29 actins (fig. 1). 
Binding to actin-tropomyosin and the inhibitory 
effect of caldesmon were closely related. Linear 
regression analysis of the data (fig.lb) gave a cor- 
relation coefficient of 0.995 and a slope which ex- 
trapolated to 100% inhibition with a total caldes- 
mon bound of 1 per 22 actins. This relationship 
has also been obtained at 25 and 37°C and con- 
firms that inhibition is due to caldesmon binding 
to the ‘strong’ sites [4,11,15]. A few measurements 
of caldesmon binding to actin gave a similar pat- 
tern of results, but binding to the (strong) sites was 
2-5-fold weaker and was not as’ closely related to 
inhibition (fig. 1) as with actin-tropomyosin. 
3.2. Bundling of actin jilaments by caldesmon 
Electron micrographs prepared from 1.1 ,uM ac- 
tin or actin-tropomyosin showed long, separate, 
randomly orientated filaments with the occasional 
parallel alignment of filaments into bundles (fig.3a, 
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b). This accounted for 3.5 -t 0.9% (mean + SE, 
n = 4) and 1.6 + 0.5% (n = 3) of the total number 
of filaments counted, respectively. In 4 separate 
preparations, caldesmon induced an increase-in the 
incidence of bundles (figs 3c, d and 4). Fig.4 shows 
where this increase reached statistical significance 
(Student’s paired t-test) compared with controls. 
On the basis of the direct relationship between 
binding and inhibition (fig.lb), it may be cal- 
culated that about 50% inhibition of MgATPase is 
achieved at 0.073 ,uM caldesmon (molar ratio of 
1: 15 caldesmon/actin, 1.1 pM actin), where 
caldesmon-induced bundling (3.0 & 1.3%, n = 4) 
was not significantly different from basal levels. 
With 0.37 PM caldesmon (1:3 molar ratio, the 
maximum tested) 90% inhibition of MgATPase 
activity was achieved, yet only 28.1 + 6.9% (n = 4) 
of actin-tropomyosin filaments were in bundles 
(increase statistically significant, p c 0.05, com- 
pared with actin-tropomyosin controls). Further- 
more, in the absence of tropomyosin there was no 
significant difference in bundling at any of the 
caldesmon concentrations tested (fig.4), yet 
caldesmon is a more potent inhibitor in the 
presence of tropomyosin (fig.lb). The increased 
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Fig.4. Bundling of 1.1 /IM F-actin (A) or 1.1 PM F-actin- 
tropomyosin (0) by vsm caldesmon. (- - -) The binding 
predicted for vsm caldesmon to high-affinity binding 
sites on actin-tropomyosin (see fig.1). Mean it- SE 
values are shown. The increase in percentage bundling 
was compared with actin or actin-tropomyosin controls 
using the paired Student’s f-test (n =4). An asterisk 
marks a probability level of p< 0.005. 
potency for actin-tropomyosin inhibition over 
actin is more pronounced at 25°C [4,15]. 
In our analysis the distribution of bundle size 
(0.37 PM caldesmon, 1.1 FM actin or actin-tropo- 
myosin) was as follows (mean values given); 2 
filaments, 22 (actin) and 53% (actin-tropomyosin); 
3 filaments, 37 and 14.5%; 4 filaments, 21 and 
13%; 5 filaments, 13.5 and 3%; 6 or more fila- 
ments, 6 and 16%. The largest bundles observed 
were of 14 filaments (0.5%, actin) and 24 filaments 
(2.570, actin-tropomyosin). Thus, the most com- 
mon number of actin filaments involved in a bun- 
dle was 2 (actin-tropomyosin) or 3 (actin) fila- 
ments. At lower caldesmon/actin ratios a similar 
pattern of bundle size distribution was seen, with 
the frequency of occurrence of larger bundles (6 or 
more filaments) decreasing as the total percentage 
of filaments bundled became reduced. Electron 
microscopy of native thin filaments showed them 
to be long and randomly orientated, with occa- 
sional parallel alignment. The degree of bundling 
observed was independent of calcium concentra- 
tion. 
3.3. Simultaneous measurement of bundling, 
binding and inhibition 
In experiments using 4.4 PM actin or actin- 
tropomyosin, inhibition, binding and bundling 
could be measured using the same protein mixtures 
(figs 2 and 3e,f). At lower caldesmon concentra 
tions (O-O.1 mol/mol actin), inhibition of Mg- 
ATPase activity and the percentage of filaments 
involved in bundles both increased. However max- 
imum bundling, involving less than 30% of actin 
filaments, was measured over the range 0.05-0.15 
caldesmon/actin (mol/mol). At higher caldesmon 
concentrations there was a decrease in bundling 
(fig.2), while inhibition of MgATPase activity was 
maintained. In our analysis, the most frequent 
bundle size measured was of 3-5 filaments, de- 
pending upon the vsm caldesmon concentration 
used. Large bundles of up to 120 filaments, as 
described by Bretscher [7], were occasionally 
observed. 
c 
Fig.3. F-Actin bundles induced by vsm caldesmon. Panels a, actin (1.1 pM); b, actin-tropomyosin (1.1 pM); c, actin 
(1.1 PM) plus caldesmon (0.37 ,uM); d, actin-tropomyosin (1.1 FM) plus caldesmon (0.37 ,uM), e, actin (4.4sM) plus 
caldesmon (1.36yM); f, actin-tropomyosin (4.4 PM) plus caldesmon (1.36 PM). No bundles are present either in a or 
b; c and d show the smaller bundles commonly seen at 1.1 /IM actin in the presence of caldesmon, while e and f show 
the less frequently occurring large bundles (4.4 pM actin). Marker bars represent 0.1 PM. 
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4. DISCUSSION 
Caldesmon is a component of thin filaments 
isolated from all smooth muscles and is proposed 
to regulate the Ca’+-dependent thin filament con- 
tractile interaction with myosin [2-4,11,12,15]. 
The key regulatory properties of caldesmon, upon 
which this proposal is based, are the inhibition of 
the myosin-actin-tropomyosin i teraction and con- 
trol of this inhibition by Ca’+ and calmodulin 
[4,8,12,15]. 
How does caldesmon inhibit actin-tropolhyosin? 
One proposal is that it aggregates actin filaments 
into bundles and that this prevents interaction with 
myosin [7,8]. In this report we tested this possibili- 
ty. 
We found that at 4°C caldesmon bound tightly 
to actin-tropomyosin and that this ‘strong’ binding 
correlated with inhibition (figs 1,2). However 
under the same conditions we observed only a 
small increase in bundling due to caldesmon. In 2 
series of experiments, at 1.1 and 4.4 PM actin- 
tropomyosin, where inhibition was up to 90%, the 
fraction of actin filaments in bundles never exceed- 
ed 30% (figs 2,4). With pure actin filaments, 
caldesmon caused less inhibition but the same 
amount of bundling. 
Native thin filaments contain 1 caldesmon per 25 
actins [l], sufficient on the basis of this work for 
inhibition but not for significant bundling. In 
practice we found that thin filament preparations 
were not bundles in Ca2+ or Ca’+-free (EGTA) 
solutions, even though their interaction with 
myosin was Ca2+-regulated. 
We therefore conclude that it is unlikely that 
bundling of filaments by caldesmon is involved in 
its regulatory function. 
Although bundles were small and infrequent 
under the conditions of our binding and Mg- 
ATPase measurements (fig.4), we did observe 
larger and more frequent bundling at higher actin 
concentrations and caldesmon/actin ratios (fig.4), 
corresponding to those described by Bretscher [7] 
and by Dabrowska et al. [6-81. We suggest that 
such bundling may be relzited to occupation of the 
‘weak’ binding sites that are not involved in regula- 
tion. In agreement with the latter authors and in 
contrast to Sobue et al. [9], bundling was observed 
with fresh protein preparation. 
It seems that many actin binding proteins can in- 
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duce bundling, including proteins such as fodrin 
[5], filamin [6], myosin subfragment-l [ 131, tropo- 
nin-I and myelin basic protein [14]. Although 
bundling properties might provide some interesting 
insight into the nature of actin-caldesmon interac- 
tions, the real inhibitory mechanism must lie 
within the smooth muscle thin filament. 
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